Lee Duna@lemmy.nz to Public Health@mander.xyz · 1 year agoFDA faces backlash over approval of genetic test for opioid addiction riskwww.nbcnews.comexternal-linkmessage-square2linkfedilinkarrow-up112arrow-down10
arrow-up112arrow-down1external-linkFDA faces backlash over approval of genetic test for opioid addiction riskwww.nbcnews.comLee Duna@lemmy.nz to Public Health@mander.xyz · 1 year agomessage-square2linkfedilink
minus-squareTacoNot@mander.xyzlinkfedilinkarrow-up4·1 year ago SOLVD Health said in its application that AvertD had demonstrated a sensitivity of about 82% and a specificity of about 79%. Those numbers suggest that roughly 1 in 5 results would be false negatives and roughly 1 in 5 would be false positives. That doesn’t seem very good
minus-squarejadero@mander.xyzlinkfedilinkarrow-up1·1 year agoTotal error rate is about 2/5? That’s barely better than a coin flip. “Oh yes, I just got tested for my potential to become an opioid addict. Give me a second to flip a coin: heads I read the report, tails I toss it in the recycle bin.”
That doesn’t seem very good
Total error rate is about 2/5? That’s barely better than a coin flip.
“Oh yes, I just got tested for my potential to become an opioid addict. Give me a second to flip a coin: heads I read the report, tails I toss it in the recycle bin.”